The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...

Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?

The Elecsys pTau181 blood test has been cleared to help rule out Alzheimer’s disease. The test correctly identified people ...

A pioneering blood test correctly identified cancer in almost two thirds of cases it highlighted so could lead to earlier ...

From cancer biology to proactive health management, customized care is changing patient outcomes, but what are the costs and accessibility challenges?

AI is transforming drug discovery, optimizing RNA molecule design, and enhancing clinical trial strategies, making it essential for companies to integrate AI into workflows. Predictive analytics in AI ...

Biomarker-driven drug development accelerates across oncology as companies advance novel mechanisms targeting previously difficult populations, with recent clinical data demonstrating high response ...

The market for biomarker discovery outsourcing is expanding rapidly, driven by precision medicine, AI analytics, and growing pharma–CRO collaborations. LONDON, UNITED KINGDOM, October 16, 2025 ...

British scientists at Oxford have developed a novel brain scan technique that may identify Alzheimer’s disease far earlier than previously possible — before any visible symptoms emerge. The method ...

On September 1, 4D Medical ushered in spring with the Big One: US Food & Drug Administration ... in the lungs. The test creates images showing how well air and blood flow are distributed throughout ...

AI in cancer diagnostics is changing the way doctors find and treat cancer. It’s not just about fancy machines—it’s about ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States Food and Drug Administration (FDA) has cleared its ...